Definition: Antimicrobial drugs inhibit microbial growth without causing significant damage to the host.
Selective Toxicity: The principle of differential toxicity to microbes versus their hosts.
Chemotherapy: Historical term for using these drugs.
Antibiotic: Refers to antimicrobial drugs derived from other microorganisms.
Gram-Positive Rods:
Bacillus subtilis: Produces Bacitracin
Paenibacillus polymyxa: Produces Polymyxin
Actinomycetes:
Streptomyces nodosus: Produces Streptomycin
Streptomyces venezuelae: Produces Erythromycin
Streptomyces aureofaciens: Produces Chlortetracycline and Tetracycline
Streptomyces griseus: Produces Gentamicin
Saccharopolyspora erythraea: Produces Amphotericin B
Micromonospora purpurea: Produces Gentamicin
Fungi:
Cephalosporium spp.: Produces Cephalothin
Penicillium chrysogenum: Produces Penicillin
Broad-Spectrum Antibiotics: Effective against various microbes (may also affect normal microflora leading to superinfections).
Narrow-Spectrum Antibiotics: Effective against limited types of microbes.
Superinfection: Results from opportunistic pathogens due to the removal of normal flora by broad-spectrum antibiotics.
Inhibition of Cell Wall Synthesis:
Examples: Penicillins, Cephalosporins, Vancomycin.
Inhibition of Protein Synthesis:
Examples: Chloramphenicol, Erythromycin, Tetracyclines.
Injury to Plasma Membrane:
Example: Polymyxin B.
Inhibition of Nucleic Acid Replication and Transcription:
Examples: Quinolones, Rifampin.
Inhibition of Essential Metabolite Synthesis:
Examples: Sulfanilamide, Trimethoprim.
Natural Penicillins: Penicillin G (injectable), Penicillin V (oral).
Semisynthetic Penicillins: Oxacillin (resistant to penicillinase), Ampicillin (broad spectrum).
Chloramphenicol: Binds to the 50S ribosomal subunit, inhibiting peptide bond formation.
Aminoglycosides (Streptomycin, Gentamicin): Bind to the 30S subunit, causing misreading of mRNA.
Tetracyclines: Inhibit tRNA attachment.
Rifampin: Blocks RNA polymerase in prokaryotes.
Quinolones: Inhibit topoisomerase, thus preventing DNA replication.
Mechanisms:
Blocking Entry: Some bacteria modify their cell wall to prevent drug access.
Enzymatic Destruction: Bacterial enzymes break down the antibiotic.
Alteration of Target: Changes bacterial targets so antibiotics cannot bind effectively.
Efflux Pumps: Bacteria pump out the antibiotics before they can exert their action.
Function: Target fungal cells without harming human cells; exploit differences in cell membrane components.
Examples:
Polyenes: Amphotericin B.
Azoles: Miconazole.
Echinocandins: Inhibit beta-glucan synthesis in fungal cell walls.
Nucleotide Analogues: Block viral DNA/RNA synthesis (e.g., Acyclovir).
Enzyme Inhibitors:
Neuraminidase Inhibitors: Prevent release of new virions (e.g., for influenza).
Entry/Fusion Inhibitors: Block virus from entering host cells.
Combination Therapy: Can have synergistic or antagonistic effects.
Overuse and Misuse: Contribute significantly to the rise of resistant bacterial strains.
New Developments: Ongoing synthesis and discovery of new antimicrobial substances from various organisms.